Quibim, a Spanish startup that’s developing foundational AI models for medical imaging spanning oncology, immunology, neurology, and metabolic disorders, has raised $50 million in a Series A round of funding.
The cash injection comes as AI makes ever deeper inroads into healthcare, spanning everything from drug discovery to clinical trials.
Quibim, for its part, is setting out to enhance diagnostic accuracy and disease detection from visual data procured from X-rays, CT scans, and MRIs. The company’s flagship product, QP-Prostate, is…
